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Abstract 
 
Mechanical circulatory support (MCS) is a lifesaving procedure in patients with 
refractory cardiogenic shock. Despite improvement in surgical techniques, ICU 
care and restored hemodynamics, some patients on MCS remain severely 
debilitated due to multiple medical problems, including infections, respiratory 
failure, de-conditioning and nutritional deficits. 
 
Here we present a case of a patient with persistent high degree fever, devastating 
muscle weakness, and elevated lactatedehydrogenase (LDH) level, who 
dramatically responded to treatment with vitamin B 12. 
Keywords: Fever of unknown origin, vitamin B12 deficiency, left ventricular assist 
device 
 
Introduction 
 
Mechanical circulatory support (MCS) is a lifesaving treatment for patients with 
refractory cardiogenic shock1. Despite improvement in surgical techniques, 
intensive care and restored hemodynamics, some patients on MCS remain 
severely debilitated due to multiple medical problems, including infections, 
respiratory failure, de-conditioning and nutritional deficits2. Here we present a case 
of a patient with persistent high degree fever, devastating muscle weakness, and 
an elevated lactate dehydrogenase (LDH) level, who dramatically responded to 
treatment with vitamin B 12. 
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Case Report 
Early Experience 
A 25-year-old male with history of repaired truncus arteriosus, placement of right 
ventricle-to-pulmonary artery homograft, bioprosthetic aortic valve replacement 
and severe left ventricular dysfunction, presented with cardiogenic shock, hypoxia 
and acute renal failure on June 1, 2015. He initially required veno-arterial 
extracorporeal membrane oxygenation (VA ECMO) support and continuous veno-
venous hemofiltration (CVVH).  Transesophageal echocardiogram showed a 
severely dilated left ventricle with an ejection fraction of 10%, severe prosthetic 
aortic valve stenosis, severe mitral valve regurgitation secondary to a flailed 
posterior leaflet segment, and moderate pulmonary stenosis. Trans-catheter aortic 
valve replacement was performed, which did not improve the patient’s condition. 
The patient developed thrombocytopenia and anemia, and required multiple blood 
transfusions. 
On June 24, 2015, the patient underwent Heartmate II left ventricular assist device 
(LVAD) implantation with mitral valve repair and replacement of the right ventricle 
to pulmonary artery conduit. Despite normalization of cardiac hemodynamics and 
recovery of renal function, the patient’s condition progressively worsened during 
the five weeks after surgery. He required a tracheostomy after failing several 
weaning trials due to an inability to clear secretions and poor oxygenation. He 
remained ventilator dependent in the ICU for six weeks.  
During this time, he developed persistent high fevers up to 40°C which did not 
respond to multiple broad spectrum antibiotics and were resistant to antipyretics 
(Figure 1A). Blood cultures and bronchoalveolar lavages were all negative for an 
infectious etiology.  Full body scans, including computed tomography (CT), 
positron emission tomography (PET), and an echocardiogram did not reveal a 
source of infection. All markers of autoimmune disease were negative.  
 
Figure 1A 
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Weaned from  
Mechanical ventilation 
In addition, the patient developed profound muscle weakness. A CT scan of the 
brain was unremarkable, electromyography (EMG) of lower extremities was 
inconclusive, and his neurological symptoms were attributed to critical illness 
myopathy.  
The patient developed anemia with macrocytosis and required several blood 
transfusions. His LDH level was elevated at 630 U/L (reference range 98-182 U/L), 
but there were no clinical signs of LVAD thrombosis. His vitamin B12 level was 
within the normal reference range, and a methylmalonic acid (MMA) level was at 
upper limit of the normal reference range (Table 1). Based on our previous 
experience with vitamin B12 treatment in the setting of fever of unknown origin 3, 
oral vitamin B12 supplementation was initiated. There was resolution of the fever 
four days after vitamin B12 initiation (Figure 1B). Importantly, no changes in 
antibiotics or other medications were made at this time. There was also a dramatic 
improvement in neurological symptoms. The patient was weaned from mechanical 
ventilation one week later. He was transferred to the cardiac step down unit ten 
days after initiating vitamin B12. He continued to improve with regard to his 
neurological condition and was discharged home from the rehabilitation unit after 
one month. His fever did not recur.  
 
 
 
 
 
Figure 1B 
Table 1 shows the hematologic data obtained prior to initiation of vitamin B12 
supplementation, one and two months after initiation vitamin B12 supplementation. 
The level of vitamin B12 increased, the concentration of MMA decreased, and the 
LDH level returned to normal range.  
 
  
 
Vitamin B 12 started Transferred 
from ICU 
 
 
 
 
 
The VAD Journal: https://doi.org/10.13023/VAD.2016.23 Page 4 of 7 
 
The VAD Journal: The journal of mechanical assisted circulation and heart failure 
 
Table 1.  The hematologic data before and after vitamin B12 supplementation 
 
 Reference range 7/15/201* 8/15/2015† 9/15/2015‡  
MCV, fL/red cell 80-96 101  98  95 
Vitamin B12, pg/mL 180-914 473  975 
MMA, μmol/L 0.00-0.40 0.4  0.2 
LDH, U/L 98-192  650 367  284  
 
* 2 weeks prior to initiation of vitamin B12 supplementation, 
† 2 weeks after initiation of vitamin B12 supplementation,  
‡ 6 weeks after initiation of vitamin B12 supplementation 
 
Discussion  
The important role of vitamin B12 and it deficiency in the hematological and 
neurological processes in human body has been well documented. However, 
vitamin B12 deficiency in patients on mechanical circulatory support has not been 
described. 
Fever was reported in patients with pernicious anemia more than 100 years ago 4.  
It usually persists after blood transfusion, despite correction of anemia, and 
resolves only after B12 administration. The mechanism of the antipyretic effect of 
vitamin B12 remains unclear 5,6. In this case of prolonged fever of unknown origin, 
the levels of vitamin B12 was near the lower limit of the normal reference range 
and the MMA level was at  the upper limit of the normal  reference range. Hence, 
the vitamin B12 treatment was not considered at an earlier point in time. Our 
patient had only transient macrocytosis. However, the typical hematological picture 
of vitamin B12 deficiency may be masked by multiple blood transfusions. The 
rational for the decision to start vitamin B12 treatment was based on anecdotal 
evidence regarding treatment of persistent fever of unknown origin in a debilitated 
patient with a mechanical mitral valve3. We observed complete resolution of the 
fever four days after vitamin B12 initiation in our patient.  
The patient developed severe muscular weakness, failed weaning from the 
ventilator, and required a prolonged ICU stay. After initiation of vitamin B12 
treatment we observed a sustained and dramatic improvement with regard to 
muscle weakness and paresthesia. Demyelization of the dorsal columns and the 
corticospinal tract resulting in peripheral neuropathy is a known complication of 
vitamin B12 deficiency. It causes irreversible neurological damage if untreated 7,8. 
A growing body of evidence demonstrates the role for vitamin B12 in the 
development, progression, and treatment of different neuropsychiatric disorders 9-
11. To date, its role in critically ill and malnourished patients on mechanical 
circulatory support has not been evaluated.  
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Hemolysis with LDH ≥ 600 IU/liter (2.5-times the upper limit of laboratory normal) 
has been identified as an important marker of thrombosis and adverse outcomes 
after left ventricular assist device implantation12,13. Furthermore, LDH elevation in 
patients with vitamin B12 deficiency is a well-recognized phenomenon and is often 
associated with both intravascular and intramedullary hemolysis and thrombosis at 
unusual sites14.  While its mechanisms are not entirely understood, it has been 
attributed to the marked hyperhomocysteinemia 15,16. Remarkably, the increased 
LDH levels rapidly returned to a normal level after initiation of vitamin B12 
treatment as in our case.   
Our case poses several issues regarding the diagnosis and appropriate treatment 
of vitamin B12 deficiency in severely debilitated and critically ill patients on 
mechanical circulatory support. First, the best diagnostic approach for vitamin B12 
deficiency in patients on mechanical circulatory support is unclear17. Second, the 
mechanism of the antipyretic effect of vitamin B12 remained inexplicit. Vitamin B12 
utilizes multiple binding proteins that facilitate its absorption and transport 18. 
Deficiency of these proteins in critically ill patients may cause functional vitamin 
B12 deficiency and result in additional difficulty in the diagnosis. It has been 
suggested that vitamin B12 has important immunomodulatory effects and its 
supplementation could correct defects caused by other biologically active 
substances under the stress of prolonged severe illness, even if the vitamin B12 
serum level is within the normal range19.  This phenomenon is called the ‘‘Master 
Key’’ effect20. Furthermore, LDH elevation in patients with vitamin B12 deficiency is 
a well-recognized phenomenon and is often associated with both intravascular and 
intramedullary hemolysis and thrombosis. The role of vitamin B12 in ventricular 
assist device thrombosis has not yet been assessed.  
Conclusion  
Vitamin B 12 supplementation in our patient was delayed due to the normal levels 
of vitamin B12 and MMA. However, the vitamin B12 deficiency was established by 
responses to therapy. The recognition and treatment of the condition was critical in 
the presented case. Since vitamin B12 has no known significant toxic effects and 
has a low cost effectiveness ratio, it should be supplemented in this patient 
population without delay. 
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